Company & Sponsor Intelligence

AbbVie

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials23

Recruiting5

Completed16

Countries5

Therapeutic footprint

alzheimersautismbipolar_disorderdepressionepilepsymigraine_headachemovement_disordersparkinsonsschizophrenia

Indexed studies

NCT06406348A Phase 1 Trial to Assess Safety, Tolerability and Pharmacokinetics of ALIA-1758 in Healthy Participants
alzheimers · United StatesPHASE1

NCT06543914Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine
migraine_headache · United StatesACTIVE_NOT_RECRUITING

NCT02906488Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease
parkinsons · JapanCOMPLETED

NCT05956483Study to Assess Accuracy of Rapid Mood Screener in Adult Participants With Unipolar Major Depressive Disorder or Bipolar 1 Disorder in Real World Setting
depression · United StatesCOMPLETED

NCT05916157An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease
parkinsons · JapanACTIVE_NOT_RECRUITING

NCT02573740Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment
alzheimers · United StatesPHASE1

NCT06605599Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder
bipolar_disorder · United StatesPHASE2

NCT03739203The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone
depression · United StatesPHASE3

NCT04500106Study to Assess Participant/Caregiver/Investigator Satisfaction of Video-Assisted Telenursing in Adult Participants With Parkinson's Disease Treated With Levodopa-Carbidopa Intestinal Gel
parkinsons · AustraliaCOMPLETED

NCT05861427Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine
migraine_headache · JapanPHASE3

NCT06618118A Study to Assess Adverse Events of Fosigotifator (ABBV-CLS-7262) in Adults With Major Depressive Disorder
depression · United StatesPHASE1

NCT03738215Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone
depression · United StatesPHASE3

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →